Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 165, Issue 1, 2014, Pages 41-51

  Kraan, Claudine M ^a   Hocking, Darren R ^a   Georgiou Karistianis, Nellie ^a   Metcalfe, Sylvia A ^b,c   Archibald, Alison D ^b,c,d   Fielding, Joanne ^a,c   Trollor, Julian ^e   Bradshaw, John L ^a   Cohen, Jonathan ^a,b,f   Cornish, Kim M ^a  

^a MONASH UNIVERSITY   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d VICTORIAN CLINICAL GENETICS SERVICES   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Fragile X Alliance Inc (Clinic and Resource Centre)   (Australia)

Author keywords

Anxiety; Attention deficit hyperactivity disorder (ADHD); Depression; Executive function; Fragile X Mental Retardation 1 (FMR1); Fragile X Mental Retardation Protein (FMRP); Fragile x associated tremor ataxia syndrome (FXTAS); Premutation

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FMR1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; EXECUTIVE FUNCTION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; SELF REPORT; SOCIAL PHOBIA; STROOP TEST; WORKING MEMORY; ANXIETY; GENETICS; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGY; PSYCHOSIS; SHORT TERM MEMORY; SOCIAL BEHAVIOR; TRINUCLEOTIDE REPEAT; YOUNG ADULT;

ADULT; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DEPRESSIVE DISORDER; EXECUTIVE FUNCTION; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; MEMORY, SHORT-TERM; MIDDLE AGED; PSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 84890248774     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32203     Document Type: Article

References (83)

1. Abbeduto L, Seltzer MM, Shattuck P, Krauss MW, Orsmond G, Murphy MM. 2004. Psychological well-being and coping in mothers of youths with autism, Down syndrome, or fragile X syndrome. Am J Ment Retard 109:237-254.
2. Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, Decarli C, Hagerman PJ, Hagerman RJ. 2010. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet Part B 153B:775-785.
3. Allen EG, Hunter JE, Rusin M, Juncos J, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. 2011. Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome. Neuropsychology 25:404-411.
4. Australian Bureau of Statistics. 2007. National Survey of Mental Health and Wellbeing: Summary of results. Canberra, Australia: Australian Bureau of Statistics.
5. Barkley RA. 1997. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 121:65-94.
6. Barkley RA, Brown TE. 2008. Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 13:977-984.
7. Battistella G, Niederhauser J, Fornari E, Hippolyte L, Gronchi Perrin A, Lesca G, Forzano F, Hagmann P, Vingerhoets FJ, Draganski B, Maeder P, Jacquemont S. 2013. Brain structure in asymptomatic FMR1 premutation carriers at risk for fragile X-associated tremor/ataxia syndrome. Neurobiol Aging 34:1700-1707.
8. Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. 2007. Fragile X-associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines. Mov Disord 22:2018-2030; quiz 2140.
9. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. 2002. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159:36-42.
10. Brown TE. 1996. Brown attention-deficit disorder scales manual. San Antonio, TX: The Psychological Corporation.
11. Burgess P, Shallice T. 1997. The Hayling and Brixton tests. Tests Manual. Bury St. Edmunds, UK: Thames Valley Test Company.
12. Chan RC, Shum D, Toulopoulou T, Chen EY. 2008. Assessment of executive functions: Review of instruments and identification of critical issues. Arch Clin Neuropsychol 23:201-216.
13. Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, Pan R, Hagerman PJ, Stenzel TT, Tassone F, Latham GJ. 2010. An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn 12:589-600.
14. Christodoulou T, Messinis L, Papathanasopoulos P, Frangou S. 2012. Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 262:125-130.
15. Cornish K, Kogan C, Turk J, Manly T, James N, Mills A, Dalton A. 2005. The emerging fragile X premutation phenotype: Evidence from the domain of social cognition. Brain Cogn 57:53-60.
16. Cornish K, Turk J, Hagerman R. 2008a. The fragile X continuum: New advances and perspectives. J Intellect Disabil Res 52:469-482.
17. Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman RJ, Hagerman PJ. 2008b. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 44:628-636.
18. Cornish KM, Kogan CS, Li L, Turk J, Jacquemont S, Hagerman RJ. 2009. Lifespan changes in working memory in fragile X premutation males. Brain Cogn 69:551-558.
19. Cornish KM, Hocking DR, Moss SA, Kogan CS. 2011. Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology 77:618-622.
20. Crawford JR, Henry JD. 2003. The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 42:111-131.
21. Crawford JR, Henry JD. 2005. Assessment of executive function. In: Halligan PW, Wade DT, editors. Effectiveness of rehabilitation for cognitive deficits. Oxford, UK: Oxford University Press.
22. Faraone SV. 2005. The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry 14:1-10.
23. Franke P, Leboyer M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, Croquette MF, Froster U, Schwab SG, Poustka F, Hautzinger M, Maier W. 1998. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80:113-127.
24. Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D. 2001. The Liebowitz Social Anxiety Scale: A comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med 31:1025-1035.
25. Galynker II, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D. 1998. Hypofrontality and negative symptoms in major depressive disorder. J Nucl Med 39:608-612.
26. Golden CJ, Freshwater SM. 2002. The Stroop Color and Word Test: Revised examiner's manual. Wood Dale, IL: Stoelting Co.
27. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. 2002. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760-1771.
28. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243-255.
29. Gyurak A, Goodkind MS, Madan A, Kramer JH, Miller BL, Levenson RW. 2009. Do tests of executive functioning predict ability to downregulate emotions spontaneously and when instructed to suppress? Cogn Affect Behav Neurosci 9:144-152.
30. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130.
31. Hashimoto R-i, Backer KC, Tassone F, Hagerman RJ, Rivera SM. 2011a. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res 45:36-43.
32. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. 2011b. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain 134:863-878.
33. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. 2011c. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord 26:1329-1336.
34. Hendrawan D, Yamakawa K, Kimura M, Murakami H, Ohira H. 2012. Executive functioning performance predicts subjective and physiological acute stress reactivity: Preliminary results. Int J Psychophysiol 84:277-283.
35. Heyder K, Suchan B, Daum I. 2004. Cortico-subcortical contributions to executive control. Acta Psychol 115:271-289.
36. Hocking DR, Kogan CS, Cornish KM. 2012. Selective spatial processing deficits in an at-risk subgroup of the fragile X premutation. Brain Cogn 79:39-44.
37. Hornberger M, Geng J, Hodges JR. 2011. Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioral variant frontotemporal dementia. Brain 134:2502-2512.
38. Hosenbocus S, Chahal R. 2012. A review of executive function deficits and pharmacological management in children and adolescents. J Can Acad Child Adolesc Psychiatry 21:223-229.
39. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. 2008a. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 38:493-502.
40. Hunter JE, Allen EG, Abramowitz A, Rusin M, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Sherman SL. 2008b. No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. Am J Hum Genet 83:692-702.
41. Hunter JE, Abramowitz A, Rusin M, Sherman SL. 2009. Is there evidence for neuropsychological and neurobehavioral phenotypes among adults without FXTAS who carry the FMR1 premutation? A review of current literature. Genet Med 11:79-89.
42. Hunter JE, Rohr JK, Sherman SL. 2010. Co-occurring diagnoses among FMR1 premutation allele carriers. Clin Genet 77:374-381.
43. Hunter JE, Epstein MP, Tinker SW, Abramowitz A, Sherman SL. 2012a. The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): Evidence for a complex inheritance. Behav Genet 42:415-422.
44. Hunter JE, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Abramowitz A, Epstein MP, Lori A, Binder E, Cubells JF, Sherman SL. 2012b. Depression and anxiety symptoms among women who carry the FMR1 premutation: Impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet Part B 159B:549-559.
45. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. 2003. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72:869-878.
46. Jacquemont S, Birnbaum S, Redler S, Steinbach P, Biancalana V. 2011. Clinical utility gene card for: Fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency. Eur J Hum Genet 19.
47. Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, Taylor A, Reiss A. 2001. Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet 103:314-319.
48. Lachiewicz AM, Dawson DV, Spiridigliozzi GA, McConkie-Rosell A. 2006. Arithmetic difficulties in females with the fragile X premutation. Am J Med Genet Part A 140A:665-672.
49. Lachiewicz A, Dawson D, Spiridigliozzi G, Cuccaro M, Lachiewicz M, McConkie-Rosell A. 2010. Indicators of anxiety and depression in women with the fragile X premutation: Assessment of a clinical sample. J Intellect Disabil Res 54:597-610.
50. Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. 2008. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology 70:1397-1402.
51. Liebowitz MR. 1987. Social phobia. Mod Probl Pharmacopsychiatry 22:141-173.
52. Loesch D, Bui QM, Grigsby J, Butler E, Epstein J, Huggins RM, Taylor AK, Hagerman RJ. 2003a. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology 17:646-657.
53. Loesch DZ, Huggins RM, Bui QM, Taylor AK, Pratt C, Epstein J, Hagerman RJ. 2003b. Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. Am J Med Genet Part A 122A:13-23.
54. Lovibond SH, Lovibond PF. 1995. Manual for the depresion anxiety stress scales. Sydney, NSW: Psychology Foundation of Australia.
55. McCarthy A, Cuskelly M, van Kraayenoord CE, Cohen J. 2006. Predictors of stress in mothers and fathers of children with fragile X syndrome. Res Dev Disabil 27:688-704.
56. Metcalfe S, Jacques A, Archibald A, Burgess T, Collins V, Henry A, McNamee K, Sheffield L, Slater H, Wake S, Cohen J. 2008. A model for offering carrier screening for fragile X syndrome to nonpregnant women: Results from a pilot study. Genet Med 10:525-535.
57. Micco JA, Henin A, Biederman J, Rosenbaum JF, Petty C, Rindlaub LA, Murphy M, Hirshfeld-Becker DR. 2009. Executive functioning in offspring at risk for depression and anxiety. Depress Anxiety 26:780-790.
58. Miyake A, Friedman NP. 2012. The nature and organization of individual differences in executive functions: Four general conclusions. Curr Dir Psychol Sci 21:8-14.
59. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. 2000. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: A latent variable analysis. Cogn Psychol 41:49-100.
60. Muniz L. 1996. Test review: Brown attention-deficit disorder scales and brown add diagnostic forms. Assess Eff Interv 22:63-74.
61. Narcisa V, Aguilar D, Nguyen DV, Campos L, Brodovsky J, White S, Adams P, Tassone F, Hagerman PJ, Hagerman RJ. 2011. A quantitative assessment of tremor and ataxia in female FMR1 premutation carriers using CATSYS. Curr Gerontol Geriatr Res. doi: 10.1155/2011/484713.
62. Ohta H, Yamagata B, Tomioka H, Takahashi T, Yano M, Nakagome K, Mimura M. 2008. Hypofrontality in panic disorder and major depressive disorder assessed by multi-channel near-infrared spectroscopy. Depress Anxiety 25:1053-1059.
63. Ottowitz WE, Dougherty DD, Savage CR. 2002. The neural network basis for abnormalities of attention and executive function in major depressive disorder: Implications for application of the medical disease model to psychiatric disorders. Harv Rev Psychiatry 10:86-99.
64. Page AC, Hooke GR, Morrison DL. 2007. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples. Br J Clin Psychol 46:283-297.
65. Ray RD, Zald DH. 2012. Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex. Neurosci Biobehav Rev 36:479-501.
66. Roberts JE, Bailey DB Jr, Mankowski J, Ford A, Sideris J, Weisenfeld LA, Heath TM, Golden RN. 2009. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet Part B 150B:130-139.
67. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, Xuncla M, Badenas C, Kulisevsky J, Gomez B, Mila M. 2009. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. Eur J Hum Genet 17:1359-1362.
68. Rucklidge JJ, Tannock R. 2002. Validity of the Brown ADD scales: An investigation in a predominantly inattentive ADHD adolescent sample with and without reading disabilities. J Atten Disord 5:155-164.
69. Rytwinski NK, Fresco DM, Heimberg RG, Coles ME, Liebowitz MR, Cissell S, Stein MB, Hofmann SG. 2009. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale. Depress Anxiety 26:34-38.
70. Schmeichel BJ, Volokhov RN, Demaree HA. 2008. Working memory capacity and the self-regulation of emotional expression and experience. J Pers Soc Psychol 95:1526-1540.
71. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1-58.
72. Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A, Tassone F, Willemsen R, Disney MD, Hagerman PJ, Todd PK, Charlet-Berguerand N. 2013. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep 3:869-880.
73. Seltzer MM, Barker ET, Greenberg JS, Hong J, Coe C, Almeida D. 2012. Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome. Health Psychol 31:612-622.
74. Seritan A, Bourgeois JA, Schneider A, Mu LY, Hagerman R, Nguyen D. 2013. Ages of onset of mood and anxiety disorders in fragile X premutation carriers. Curr Psychiatry Rev 9:65-71.
75. Sherman SL. 2000. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 97:189-194.
76. Sterling AM, Mailick M, Greenberg J, Warren SF, Brady N. 2013. Language dysfluencies in females with the FMR1 premutation. Brain Cogn 82:84-89.
77. Steyaert J, Legius E, Borghgraef M, Fryns J-P. 2003. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks. Am J Med Genet Part A 116A:44-51.
78. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15.
79. Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ. 2012. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav 11:577-585.
80. Wang JM, Koldewyn K, Hashimoto R, Schneider A, Li L, Tassone F, Cheung K, Hagerman P, Hessl D, Rivera SM. 2012. Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding. Front Hum Neurosci 6:1-13.
81. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. 2005. Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review. Biol Psychiatry 57:1336-1346.
82. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. 2007. The FMR1 premutation and reproduction. Fertil Steril 87:456-465.
83. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. 2013. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol 20:23933.